Opioid-induced hyperalgesia: Is it clinically relevant for the treatment of pain patients?

Pain Management Nursing

Volumn 14, Issue 3, 2013, Pages

  Raffa, Robert B ^a   Pergolizzi, Joseph V ^b,c  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG TOLERANCE; HUMAN; HYPERALGESIA; PAIN; PAIN ASSESSMENT; REVIEW;

ANALGESICS, OPIOID; ANIMALS; DRUG TOLERANCE; HUMANS; HYPERALGESIA; PAIN; PAIN MEASUREMENT;

EID: 84882731634     PISSN: 15249042     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmn.2011.04.002     Document Type: Review

References (166)

1. Ali N. Hyperalgesic response in a patient receiving high concentrations of spinal morphine. Anesthesiology 1986, 65:449.
2. Andrews H. The effects of opiates on the pain thresholds in post-addicts. The Journal of Clinical Investigation 1943, 22:511-516.
3. Angst M.S., Chu L.F., Clark J.D. Overview on clinical features of opioid-induced hyperalgesia. Opioid-induced hyperalgesia 2010, 21-37. Informa Healthcare, New York, NY. J. Mao (Ed.).
4. Angst M.S., Clark J.D. Opioid-induced hyperalgesia: A qualitative systematic review. Anesthesiology 2006, 104(3):570-587.
5. Angst M.S., Koppert W., Pahl I., Clark D.J., Schmelz M. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 2003, 106(1-2):49-57.
6. Arner S., Rawal N., Gustafsson L.L. Clinical experiences of long-term treatment with epidural and intrathecal opioids-a nationwide survey. Acta Anaesthesiologica Scandinavica 1988, 32:253-259.
7. Ballantyne J.C. Opioid tolerance, dependence, and hyperalgesia. Opioid-induced hyperalgesia 2010, 61-73. Informa Healthcare, New York, NY. J. Mao (Ed.).
8. Ballantyne J., Mao J. Opioid therapy for chronic pain. The New England Journal of Medicine 2003, 349:1943-1953.
9. Bannister K., Dickenson A.H. Opioid hyperalgesia. Current Opinion in Supportive and Palliative Care 2010, 4(1):1-5.
10. Bederson J., Fields H., Barbaro N.M. Hyperalgesia during naloxone-precipitated withdrawal from morphine is associated with increased on-cell activity in the rostral ventromedial medulla. Somatosensory Motor Research 1990, 7:185-203.
11. Biondi D.M. Is migraine a neuropathic pain syndrome?. Current Pain Headache Report 2006, 10(3):167-178.
12. Bodnar R.J., Kest B. Sex differences in opioid analgesia, hyperalgesia, tolerance and withdrawal: Central mechanisms of action and roles of gonadal hormones. Hormones and Behavior 2010, 58(1):72-81.
13. Bruggemann I., Schulz S., Wiborny D., Hollt V. Colocalization of the mu-opioid receptor and calcium/calmodulin dependent kinase II in distinct pain-processing brain regions. Brain Research Molecular Brain Research 2000, 85(1-2):239-250.
14. Carlton S. Localization of CaMKII-alpha in rat primary sensor neurons: Increase in inflammation. Brain Research 2002, 947:252-259.
15. Célèrier E., Laulin J., Larcher A., le Moal M., Simonnet G. Evidence for opiate-activaed NMDA processes masking opiate analgesia in rats. Brain Research 1999, 847(1):18-25.
16. Célèrier E., Rivat C., Jun Y., Laulin J.P., Larcher A., Reynier P., Simonnet G. Long-lasting hyperalgesia induced by fentanyl in rats: Preventive effect of ketamine. Anesthesiology 2000, 92(2):465-472.
17. Célèrier E., Laulin J.P., Corcuff J.B., le Moal M., Simonnet G. Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: A sensitization process. The Journal of Neuoroscience 2001, 21(11):4074-4080.
18. Chakrabarti S., Yang W., Law P.Y., Loh H.H. The mu-opioid receptor downregulates differently from the delta-opioid receptor: Requirement of a high affinity receptor/G protein complex formation. Molecular Pharmacology 1997, 52(1):105-113.
19. Chen L., Malarick C., Seefeld L., Wang S., Houghton M., Mao J. Altered quantitative sensing testing outcome in subjects with opioid therapy. Pain 2009, 143(1-2):65-70.
20. 2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia. The Journal of Neuroscience 2010, 30(1):38-46.
21. Chia Y.Y., Liu K., Wang J.J., Kuo M.C., Ho S.T. Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Canadian Journal of Anesthesia 1999, 46(9):827-877.
22. Chu L.F., Clark D.J., Angst M.S. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: A preliminary prospective study. Journal of Pain 2006, 7(1):43-48.
23. Coderre T., Melzack R. Increased pain sensitivity following heat injury involves a central mechanism. Behavioural Brain Research 1985, 14:259-262.
24. Cohen S.P., Christo P.J., Wang S., Chen L., Stojanovic M.P., Shields C.H., Brummet C., Mao J. The effect of opioid dose and treatment duration onthe perception of a painful standardized clinical stimulus. Regional Anesthesia and Pain Management 2008, 33(3):199-206.
25. Colpaert F. System theory of pain and of opiate analgesia: No tolerance to opiates. Pharmacological Reviews 1996, 48(3):355-402.
26. Compton M. Cold-pressor pain tolerance in opiate and cocaine abusers: Correlates of drug type and use status. Journal of Pain Symptom Management 1994, 9(7):462-473.
27. Compton P., Athanasos P., Elashoff D. Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: A preliminary study. The Journal of Pain 2003, 4(9):511-519.
28. Compton P., Charuvastra V., Kintaudi K., Ling W. Pain responses in methadone-maintained opioid abusers. The Journal of Pain Symptom Management 2000, 20(4):237-245.
29. Compton P., Charuvastra V.C., Ling W. Pain intolerance in opioid-maintained former opiate addicts: Effect of long-acting maintenance agent. Drug and Alcohol Dependence 2001, 63(2):139-146.
30. Compton P., Miotto K., Elashoff D. Precipitated opioid withdrawal across acute physical dependence induction methods. Pharmacology Biochemistry and Behavior 2004, 77(2):263-268.
31. Cooper D.W., Lindsay S.L., Ryall D.M., Kokri M.S., Eldabe S.S., Lear G.A. Does intrathecal fentanyl produce acute cross-tolerance to i.v. morphine?. British Journal of Anaesthesia 1997, 78(3):311-313.
32. Cortínez L.I., Brandes V., Muñoz H.R., Guerrero M.E., Mur M. No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia. British Journal of Anaesthesia 2001, 87(6):866-869.
33. Crain S., Shen K. Opioids can evoke direct receptor mediated excitatory effects on sensory neurons. National Institute of Drug Abuse Research Monograph 1990, 105:34-39.
34. Crain S.M., Shen K.F. Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain 2000, 84(2-3):121-131.
35. Crain S.M., Shen K.F. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia. Brain Research 2001, 888(1):75-82.
36. Crawford M.W., Hickey C., Zaarour C., Howard A., Naser B. Development of acute opioid tolerance during infusion of remifentail for pediatric scoliosis surgery. Anesthesia & Analgesia 2006, 102(6):1662-1667.
37. Crofford L. Adverse effects of chronic opioid therapy for chronic muscoskeletal pain. Nature Reviews Rheumatology 2010, 6:191-197.
38. Cvejic S., Trapaidze N., Cyr C., Devi L.A. Thr353, located within the COOH-terminal tail of the delta opiate receptor, is involved in receptor down-regulation. The Journal of Biological Chemistry 1996, 271(8):4073-4076.
39. Davis A.M., Inturrisi C.E. d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia. Journal of Pharmacological and Experimental Therapy 1999, 289(2):1048-1053.
40. Davis M.P., Shaiova L.A., Angst M.S. When opioids cause pain. The Journal of Clinical Oncology 2007, 25(28):4497-4498.
41. de Conno F., Caraceni A., Martini C., Spoldi E., Salvetti M., Ventafridda V. Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine. Pain 1991, 47(3):337-339.
42. Derrode N., Lebrun F., Levron J.C., Chauvin M., Debaene B. Influence of perioperative opioid on postoperative pain after major abdominal surgery: Sufentanil TCI versus remifentanil TCI. A randomized, controlled study. British Journal of Anaesthesia 2003, 91(6):842-849.
43. Devillers J.P., Boisserie F., Laulin J.P., Larcher A., Simonnet G. Simultaneous activation of spinal antiopioid system (neuropeptide FF) and pain facilitatory circuitry by stimulation of opioid receptors in rats. Brain Research 1995, 700(1-2):173-181.
44. Devulder J. Hyperalgesia induced by high-dose intrathecal sufentanil in neuropathic pain. The Journal of Neurosurgical Anesthesiology 1997, 9(2):146-148.
45. Devulder J., Bohyn P., Castille F., De Laat M., Rolly G. A case of uncommon withdrawal symptoms after a short period of spinal morphine administration. Pain 1996, 64(3):589-591.
46. Doverty M., Somogyi A.A., White J.M., Bochner F., Beare C.H., Menelaou A., Ling W. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain 2001, 93(2):155-163.
47. Doverty M., White J.M., Somogyi A.A., Bochner F., Ali R., Ling W. Hyperalgesic responses in methadone maintenance patients. Pain 2001, 90(1-2):91-96.
48. Dunbar S.A., Pulai I.J. Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat. Journal of Pharmacology and Experimental Therapeutics 1998, 284(2):678-686.
49. DuPen A., Shen D., Ersek M. Mechanisms of opioid-induced tolerance and hyperalgesia. Pain Management Nursing 2007, 8(3):113-121.
50. Dyer K.R., Foster D.J., White J.M., Somogyi A.A., Menelao A., Bochner F. Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: Comparison of those who do and do not experience withdrawal and concentration-effect relationships. Clinical Pharmacology & Therapeutics 1999, 65(6):685-694.
51. Eisenach J. Preemptive hyperalgesia, not analgesia?. Anesthesiology 2000, 92:308-309.
52. Ekblom M., Hammarlund-Udenaes M., Paalzow L. Modeling of tolerance development and rebound effect during different intravenous administration of morphine to rats. Journal of Pharmacology and Experimental Therapeutics 1993, 266(1):244-252.
53. Engelhardt T., Zaarour C., Naser B., Pehora C., de Ruiter J., Howard A., Crawford M.W. Intraoperative low-dose ketamine does not prevent a remifentanil-induced increase in morphine requirement after pediatric scoliosis surgery. Anesthesia & Analgesia 2008, 107(4):1170-1175.
54. Ferrari L.F., Bogen O., Levine J.D. Nociceptor subpopulations involved in hyperalgesic priming. Neuroscience 2010, 165(3):896-901.
55. Fillingim R.B., Doleys D.M., Edwards R.R., Lowery D. Clinical characteristics of chronic back pain as a function of gender and oral opioid use. Spine 2003, 28(2):143-150.
56. Fishbain D.A., Cole B., Lewis J.E., Gao J., Rosomoff R.S. Do opioids induce hyperalgesia in humans? An evidence-based structured review. Pain Medicine 2009, 10(5):829-839.
57. Freye E., Levy J.V. No hyperalgesia following opioid withdrawal after the oripavine derivative etorphine compared to remifentanil and sufentanil. European Journal of Anaesthesiology 2010, 27(2):174-180.
58. Gardell L.R., King T., Ossipov M.H., Rice K.C., Lai J., Vanderah T.W., Porreca F. Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery. Neuroscience Letters 2006, 396(1):44-49.
59. Gardell L.R., Wang R., Burgess S.E., Ossipov M.H., Vanderah T.W., Malan T.P., Lai J., Porreca F. Sustained morphine exposure induced a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers. The Journal of Neuoroscience 2002, 22(15):6747-6755.
60. Goldfarb J., Kaplan E.I., Jenkins H.R. Interaction of morphine and naloxone in acute spinal cats. Neuropharmacology 1978, 17(8):569-575.
61. Grilly D., Gowans G. Acute morphine dependence: Effects observed in shock and light discrimination tasks. Psychopharmacology (Berlin) 1986, 88:500-504.
62. Gu X., Wu X., Liu Y., Cui S., Ma Z. Tyrosine phosphorylation of the N-methyl-D-aspartate receptor 2B subunit in spinal cord contributes to remifentanil-induced postoperative hyperalgesia: The preventive effect of ketamine. Molecular Pain 2009, 5:76.
63. Guignard B., Bossard A.E., Coste C., Sessler D.I., Lebrault C., Alfonsi P., Fletcher D., Chauvin M. Acute opioid tolerance: Intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 2000, 93(2):409-417.
64. Heit H., Covington E., Good P.M. Dear DEA. Pain Medicine 2004, 5:303-308.
65. Hood D.D., Curry R., Eisenach J.C. Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia. Anesthesia & Analgesia 2003, 97(3):810-815.
66. Hutchinson M.R., Bland S.T., Johnson K.W., Rice K.W., Maier S.F., Watkins L.R. Opioid-induced glial activation: Mechanisms of activation and implications for opioid analgesia, dependence, and reward. Scientific World Journal 2007, 7:98-111.
67. Hutchinson M.R., Lewis S.S., Coats B.D., Rezvani N., Zhang Y., Wieseler J.L., Somogyi A.A., Yin H., Maier S.F., Rice K.C., Watkins L.R. Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences. Neuroscience 2010, 167(3):880-893.
68. Ibuki T., Dunbar S., Yaksh T.L. Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal morphine infusion. Pain 1997, 70:125-132.
69. Induru R., Davis D. Buprenorphine for neuropathic pain-targeting hyperalgesia. American Journal of Hospice and Palliative Medicine 2009, 26(6):470-473.
70. Inturrisi C. The role of N-methyl-D-aspartate (NMDA) receptors in pain and morphine tolerance. Minerva Anestesiologica 2005, 7(7-8):401-403.
71. Jensen K.B., Lonsdorf T.B., Schalling M., Kosek E., Ingvar M. Increased sensitivity to thermal pain following a single opiate dose is influenced by the COMT val(158)met polymorphism. PLoS One 2009, 4(6):e6016.
72. Johnson S., Duggan A. Tolerance and dependence of dorsal horn neurones of the cat: The role of opiate receptors of the substantia gelatinosa. Neuropharmacology 1981, 20:1033-1038.
73. Joly V., Richebe P., Guignard B., Fletcher D., Maurette P., Sessler D.I., Chauvin M. Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology 2005, 103(1):147-155.
74. Joseph E.K., Reichling D.B., Levine J.D. Shared mechanisms for opioid tolerance and a transition to chronic pain. Journal of Neuroscience 2010, 30(13):4660-4666.
75. Juni A., Cai M., Stankova M., Waxman A.R., Arout C., Klein G., Dahan A., Hruby V.J., Mogil J.S., Kest B. Sex-specific mediation of opioid-induced hyperalgesia by the melanocortin-1 receptor. Anesthesiology 2010, 112(1):181-188.
76. Juni A., Klein G., Kest B. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: Evidence for multiple diverse hyperalgesic systems. Brain Research 2006, 1070(1):35-44.
77. Juni A., Klein G., Kowalczyk B., Ragnauth A., Kest B. Sex differences in hyperalgesia during morphine infusion: Effect of gonadectomy and estrogen treatment. Neuropharmacology 2008, 54(8):1264-1270.
78. Juni A., Klein G., Pintar J.E., Kest B. Nociception increases during opioid infusion in opioid receptor triple knock-out mice. Neuroscience 2007, 147(2):439-444.
79. Kaplan H., Fields H. Hyperalgesia during acute opioid abstinence: Evidence for a nociceptive facilitating function of the rostral ventromedial medulla. The Journal of Neuroscience 1991, 11:1433-1439.
80. Katz J., Seltzer Z. Transition from acute to chronic postsurgical pain: Risk factors and protective factors. Expert Review of Neurotherapeutics 2009, 9(5):723-744.
81. Kim D.H., Barbaro N., Fields H.L. Dose response relationship for hyperalgesia following naloxone precipitated withdrawal from morphine. Society for Neuroscience Annual Meeting, Toronto, Canada, Abstracts 1988, 14:174.
82. King T., Gardell L.R., Wang R., Vardanyan A., Ossipov M.H., Malan T.P., Vanderah T.W., Hunt S.P., Hruby V.J., Lai J., Porreca F. Role of NK-1 neurotransmission in opioid-induced hyperalgesia. Pain 2005, 116(3):276-288.
83. King T., Ossipov M.H., Vanderah T.W., Porreca F., Lai J. Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance?. Neurosignals 2005, 14(4):194-205.
84. Kiss I., Degryse A.D., Bardin L., Gomez de Segura I.A., Colpaert F.C. The novel analgesic, F 13640, produces intra- and postoperative analgesia in a rat model of surgical pain. European Journal of Pharmacology 2005, 523(1-3):29-39.
85. Koppert W., Angst M., Alsheimer M., Sittl R., Albrecht S., Schüttler J., Schmelz M. Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans. Pain 2003, 106(1-2):91-99.
86. Koppert W., Ihmsen H., Körber N., Wehrfritz A., Sittl R., Schmelz M., Schüttler J. Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model. Pain 2005, 118(1-2):15-22.
87. Koppert W., Sittl R., Scheuber K., Alsheimer M., Schmelz M., Schüttler J. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology 2003, 99(1):152-159.
88. Kovacs F.M., Abraira V., Zamora J., Fernández C. The transition from acute to subacute and chronic low back pain: A study based on determinants of quality of life and prediction of chronic disability. Spine 2005, 30(15):1786-1792. Spanish Back Pain Research Network.
89. Lai J., Luo M.C., Chen Q., Ma S., Gardell L.R., Ossipov M.H., Porreca F. Dynorphin A activates bradykinin receptors to maintain neuropathic pain. Nature Neuroscience 2006, 9(12):1534-1540.
90. Larcher A., Laulin J.P., Célèrier E., le Moal M., Simonnet G. Acute tolerance associated with a single opiate administration: Involvement of N-methyl-D-aspartate-dependent pain facilitatory systems. Neuroscience 1998, 84(2):583-589.
91. Laulin J.P., Maurette P., Corcuff J.B., Rivat C., Chauvin M., Simonnet G. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesthesia & Analgesia 2002, 94(5):1263-1269.
92. Le Bars D., Guilbaud G., Jurna I., Besson J.M. Differential effects of morphine on responses of dorsal horn lamina V type cells elicited by A and C fibre stimulation in the spinal cat. Brain Research 1976, 115(3):518-524.
93. Leknes S., Brooks J.C., Wiech K., Tracey I. Pain relief as an opponent process: A psychophysical investigation. European Journal of Neuroscience 2008, 28(4):794-801.
94. Li X., Angst M.S., Clark J.D. A murine model of opioid-induced hyperalgesia. Brain Research Molecular Brain Research 2001, 86(1-2):56-62.
95. Li X., Angst M.S., Clark J.D. Opioid-induced hyperalgesia and incisional pain. Anesthesia & Analgesia 2001, 93(1):204-209.
96. Liang D.Y., Liao G., Wang J., Usuka J., Guo Y., Peltz G., Clark D. A genetic analysis of opioid-induced hyperalgesia in mice. Anesthesiology 2006, 104(5):1054-1062.
97. Ling W., Compton P. Challenging clinical issues on the interaction between addiction and hyperalgesia. Opioid-induced hyperalgesia 2010, 74-94. Informa Healthcare, New York, NY. J. Mao (Ed.).
98. Lipman I., Blumenkopf B. Comparison of subjective and objective analgesic effects of intravenous and intrathecal morphine in chronic pain patients by heat beam dolorimetry. Pain 1989, 39:249-256.
99. Luginbühl M., Gerber A., Schnider T.W., Petersen-Felix S., Arendt-Nielsen L., Curatolo M. Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans. Anesthesia & Analgesia 2003, 96(3):726-732.
100. MacDonald J.F., Bartlett M.C., Mody I., Pahapill P., Reynolds J.N., Salter M.W., Scheniderman J.H., Pennefathers P.S. Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurons. The Journal of Physiology 1991, 432:483-508.
101. Mao J. NMDA and opioid receptors: Their interactions in antinociception, tolerance and neuroplasticity. Brain Research Reviews 1999, 30:289-304.
102. Mao J. Opioid-induced abnormal pain sensitivity: Implications in clinical opioid therapy. Pain 2002, 100(3):213-217.
103. Mao J. Opioid-induced abnormal pain sensitivity. Current Pain and Headache Reports 2006, 10(1):67-70.
104. Mao J. Overview of opioid-induced hyperalgesia. Opioid-induced hyperalgesia 2010, 1-8. Informa Healthcare, New York, NY. J. Mao (Ed.).
105. Mao J., Mayer D.J. Spinal cord neuroplasticity following repeated opioid exposure and its relation to pathological pain. Annals of the New York Academy of Science 2001, 933:175-184.
106. Mao J., Price D., Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: Roles of excitatory amino acid receptors and protein kinase C. The Journal of Neuroscience 1994, 14:2301-2312.
107. Mao J., Price D., Mayer D.J. Mechanisms of hyperalgesia and opiate tolerance: A current view of their possible interactions. Pain 1995, 62:259-274.
108. Mao J., Sung B., Ji R.R., Lim G. Neuronal apoptosis associated with morphine tolerance: Evidence from an opioid-induced neurotoxic mechanism. The Journal of Neuroscience 2002, 22(17):7650-7661.
109. Mao J., Sung B., Ji R.R., Lim G. Chronic morphine induces downregulation of spinal glutamate transporters: Implications in morphine tolerance and abnormal pain sensitivity. The Journal of Neuroscience 2002, 22(18):8312-8323.
110. Martin W., Eades C. A comparison between acute and chronic physical dependence in the chronic spinal dog. Journal of Pharmacological and Experimental Therapeutics 1964, 146:385-394.
111. Martin W.R., Gilbert P.E., Jasinski D.R., Martin C.D. An analysis of naltrexone precipitated abstinence in morphine-dependent chronic spinal dogs. Journal of Pharmacological and Experimental Therapeutics 1987, 240(2):565-570.
112. Mayer D.J., Mao J., Holt J., Price D.D. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proceedings of the National Academy of Sciences of the United States of America 1999, 96(14):7731-7736.
113. McCarberg B. Practical management of opioid-induced hyperalgesia in the primary care setting. Opioid-induced hyperalgesia 2010, 95-102. Informa Healthcare, New York, NY. J. Mao (Ed.).
114. Meng I., Harasawa I. Chronic morphine exposure increases the proportion of oncells in the rostral ventromedial medulla in rats. Life Sciences 2007, 80(20):1915-1920.
115. Minville V., Fourcade O., Girolami J.P., Tack I. Opioid-induced hyperalgesia in a mice model of orthopaedic pain: Preventive effect of ketamine. British Journal of Anaesthesia 2010, 104(2):231-238.
116. Miser A.W., Chayt K.J., Sandlund J.T., Cohen P.S., Dothage J.A., Miser J.S. Narcotic withdrawal syndrome in young adults after the therapeutic use of opiates. American Journal of Diseases of Children 1986, 140(6):603-604.
117. Mitchell S. Characteristics 1905, Century, New York, NY.
118. Morgan D., Carter C.S., DuPree J.P., Yezierski R.P., Vierck C.J. Evaluation of prescription opioids using operant-based pain measures in rats. Experimental and Clinical Psychopharmacology 2008, 16(5):367-375.
119. Neziri A.Y., Curatolo M., Nüesch E., Scaramozzino P., Andersen O.K., Arendt-Nielsen L., Jüni P. Factor analysis of responses to thermal, electrical, and mechanical painful stimuli suppors the importance of multi-modal pain assessment. Pain 2011, 152(5):1146-1155.
120. Ossipov M.H., Lai J., King T., Vanderah T.W., Porreca F. Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure. Biopolymers 2005, 80(2-3):319-324.
121. Ossipov M.H., Lai J., King T., Vanderah T.W., Malan T.P., Hruby V.J., Porreca F. Antinociceptive and nociceptive actions of opioids. Journal of Neurobiology 2004, 61(1):126-148.
122. Ossipov M.H., Lopez Y., Nichols M.L., Bian D., Porreca F. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive. Neuroscience Letters 1995, 199(2):87-90.
123. Petersen K.L., Meadoff T., Press S., Peters M.M., LeComte M.D., Rowbotham M.C. Changes in morphine analgesia and side effects during daily subcutaneous administration in healthy volunteers. Pain 2008, 137(2):395-404.
124. Potter J.M., Reid D.B., Shaw R.J., Hackett P., Hickman P.E. Myoclonus associated with treatment with high doses of morphine: The role of supplemental drugs. British Medical Journal 1989, 299(6692):150-153.
125. Pud D., Cohen D., Lawental E., Eisenberg E. Opioids and abnormal pain perception: New evidence from a study of chronic opioid addicts and healthy subjects. Drug and Alcohol Dependence 2006, 82(3):218-223.
126. Ram K.C., Eisenberg E., Haddad M., Pud D. Oral opioid use alters DNIC but not cold pain perception in patients with chronic pain-new perspective of opioid-induced hyperalgesia. Pain 2008, 139(2):431-438.
127. Reichling D., Levine J. Critical role of nociceptor plasticity in chronic pain. Trends in Neurosciences 2009, 32(12):611-618.
128. Reznikov I., Pud D., Eisenberg E. Oral opioid administration and hyperalgesia in patients with cancer or chronic nonmalignant pain. British Journal of Clinical Pharmacology 2005, 60(3):311-318.
129. Richebé P., Rivalan B., Rivat C., Laulin J.P., Janvier G., Maurette P., Simonnet G. Effects of sevoflurane on carrageenan- and fentanyl-induced pain hypersensitivity in Sprague-Dawley rats. Canadian Journal of Anaesthesia 2009, 56(2):126-135.
130. Richebé P., Rivat C., Laulin J.P., Maurette P., Simonnet G. Ketamine improves the management of exaggerated postoperative pain observed in perioperative fentanyl-treated rats. Anesthesiology 2005, 102(2):421-428.
131. Rivat C., Laulin J.P., Corcuff J.B., Célèrier E., Pain L., Simonnet G. Fentanyl enhancement of carrageenan-induced long-lasting hyperalgesia in rats: Prevention by the N-methyl-D-aspartate receptor antagonist ketamine. Anesthesiology 2002, 96(2):381-391.
132. National survey on drug use and health Substance Abuse and Mental Health Services Administration, Retrieved March 25, 2011, from:. https://nsduhweb.rti.org.
133. Saper J.R., Lake A.E. Continuous opioid therapy (COT) is rarely advisable for refractory chronic daily headache: Limited efficacy, risks, and proposed guidelines. Headache 2008, 48(6):838-849.
134. Schall U., Katta T., Pries E., Klöppel A., Gastpar M. Pain perception of intravenous heroin users on maintenance therapy with levomethadone. Pharmacopsychiatry 1996, 29(5):176-179.
135. Shen K.F., Crain S.M. Cholera toxin-B subunit blocks excitatory opioid receptor-mediated hyperalgesic effects in mice, thereby unmasking potent opioid analgesia and attenuating opioid tolerance/dependence. Brain Research 2001, 919(1):20-30.
136. Silverman S.M. Opioid induced hyperalgesia: Clinical implications for the pain practitioner. Pain Physician 2009, 12(3):679-684.
137. Simonnet G., Rivat C. Opioid-induced hyperalgesia: Normal or abnormal pain?. Neuroreport 2003, 14(1):1-7.
138. Singla A., Stojanovic M.P., Chen L., Mao J. A differential diagnosis of hyperalgesia, toxicity, and withdrawal from intrathecal morphine infusion. Anesthesia & Analgesia 2007, 105(6):1816-1819.
139. Sjøgren P., Jensen N.H., Jensen T.S. Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists. Pain 1994, 59(2):313-316.
140. Sjøgren P., Jonsson T., Jensen N.H., Drenck N.E., Jensen T.S. Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine. Pain 1993, 55(1):93-97.
141. Suzuki R., Porreca F., Dickenson A.H. Evidence for spinal dorsal horn hyperexcitability in rats following sustained morphine exposure. Neuroscience Letters 2006, 407(2):156-161.
142. Tilson H.A., Rech R.H., Stolman S. Hyperalgesia during withdrawal as a means of measuring the degree of dependence in morphine dependent rats. Psychopharmacologia 1973, 28(3):287-300.
143. Trang T., McNaull B., Quirion R., Jhamandas K. Involvement of spinal lipoxygenase metabolites in hyperalgesia and opioid tolerance. European Journal of Pharmacology 2004, 491(1):21-30.
144. Trang T., Sutak M., Jhamandas K. Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance. Neuroscience 2007, 146(3):1275-1288.
145. Ueda H. Cellular mechanisms underlying morphine analgesic tolerance and hyperalgesia. Opioid-induced hyperalgesia 2010, 9-20. Informa Healthcare, New York, NY. J. Mao (Ed.).
146. Ueda H., Ueda M. Mechanisms underlying morphine analgesic tolerance and dependence. Frontiers in Bioscience 2009, 14:5260-5272.
147. Vanderah T.W., Ossipov M.H., Lai J., Malan T.P., Porreca F. Mechanisms of opioid-induced pain and antinociceptive tolerance: Descending facilitation and spinal dynorphin. Pain 2001, 92(1-2):5-9.
148. Vanderah T.W., Gardell L.R., Burgess S.E., Ibrahim M., Dogrul A., Zhong C.M., Zhang E.T., Malan T.P., Ossipov M.H., Lai J., Porreca F. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. Journal of Neuroscience 2000, 20(18):7074-7079.
149. Vera-Portocarrero L., Zhang E., Ossipov M.H., Xie J.Y., King T., Lai J., Porreca F. Descending facilitation from the rostral ventromedial medulla maintains nerve injury-induced central sensitization. Neuroscience 2006, 140(4):1311-1320.
150. Vera-Portocarrero L., Zhang E., King T., Ossipov M.H., Vanderah T.W., Lai J., Porreca F. Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways. Pain 2007, 129(1-2):35-45.
151. Vinik H., Kissin I. Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesthesia & Analgesia 1998, 86(6):1307-1311.
152. Vorobeychik Y. Role of ketamine in managing opioid-induced hyperalgesia. Opioid-induced hyperalgesia 2010, 124-133. Informa Healthcare, New York, NY. J. Mao (Ed.).
153. Vorobeychik Y., Chen L., Bush M.C., Mao J. Improved opioid analgesic effect following opioid dose reduction. Pain Medicine 2008, 9(6):724-727.
154. Wang C.K., Myunghae Hah J., Carroll I. Factors contributing to pain chronicity. Current Pain and Headache Reports 2009, 13(1):7-11.
155. Wang H., Burns L. Gbetagamma that interacts with adenylyl cyclase in opioid tolerance originates from a Gs protein. Journal of Neurobiology 2006, 66(12):1302-1310.
156. Watkins L.R., Hutchinson M.R., Johnston I.N., Maier S.F. Glia: Novel counter-regulators of opioid analgesia. Trends in Neurosciences 2005, 28(12):661-669.
157. Watkins L.R., Milligan E.D., Maier S.F. Glial activation: A driving force for pathological pain. Trends in Neurosciences 2001, 24(8):450-455.
158. Webster B.S., Verma S.K., Gatchel R.J. Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use. Spine 2007, 32(19):2127-2132.
159. Wegert S., Ossipov M.H., Nichols M.L., Bian D., Vanderah T.W., Malan T.P., Porreca F. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats. Pain 1997, 71(1):57-64.
160. Werz M., MacDonald R. Opiate alkaloids antagonizepostsynaptic glycine and GABA response: Correlationwith convulsant action. Brain Research 1982, 236(1):107-119.
161. Woolf C., Salter M. Neuronal plasticity: Increasing the gain in pain. Science 2000, 288(5472):1765-1769.
162. Xie J.Y., Herman D.S., Stiller C.O., Gardell L.R., Ossipov M.H., Lai J., Porreca F., Vanderah T.W. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. The Journal of Neuroscience 2005, 25(2):409-416.
163. 1A receptor-mediated inverse tolerance. Trends in Pharmacological Sciences 2003, 24(12):634-639.
164. Yaksh T.L., Harty G.J., Onofrio B.M. High dose of spinal morphine produces a nonopiate receptor-mediated hyperesthesia: Clinical and theoretic implications. Anesthesiology 1986, 64(5):590-597.
165. Young Casey C., Greenberg M.A., Nicassio P.M., Harpin R.E., Hubbard D. Transition from acute to chronic pain and disability: A model including cognitive, affective, and trauma factors. Pain 2008, 134(1):69-79.
166. Zhao M., Joo D.T. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance. Anesthesiology 2008, 109(2):308-317.